Key Takeaways
- • TPG is exploring a sale of Lyric, its healthcare software company specializing in payment-integrity solutions, with an anticipated valuation of approximately $5 billion.
- • JPMorgan Chase is advising TPG on the sale process, indicating institutional-grade transaction infrastructure and broad potential buyer reach.
- • Lyric operates in the healthcare payments sector, a strategically valuable segment given ongoing industry consolidation and digital transformation in healthcare infrastructure.
- • The sale represents a significant exit opportunity for TPG's healthcare technology portfolio and could attract strategic and financial buyers across healthcare, fintech, and software sectors.
Summary
TPG is evaluating a strategic exit from Lyric, a healthcare software company focused on payment-integrity solutions, through a process that could value the business at approximately $5 billion. The sale exploration was first reported by Reuters on September 10, 2026, with JPMorgan Chase retained as the financial advisor managing the transaction process. This engagement with a leading investment bank signals TPG's intent to conduct a formal, broad-based sale process rather than a bilateral negotiation.
Lyric operates within the healthcare industry's payments infrastructure, providing software solutions that support payment processing and integrity in the healthcare sector. This positioning places the company at the intersection of two structural growth trends: digital transformation of healthcare operations and increasing focus on payment accuracy and compliance. The $5 billion valuation reflects the strategic value assigned to this business segment within TPG's portfolio.
The sale process underscores ongoing consolidation activity within healthcare technology and fintech sectors, where software platforms addressing mission-critical payment and regulatory functions command premium valuations. With JPMorgan coordinating the process, potential bidders likely span strategic buyers in healthcare services, payment processors, software-as-a-service providers, and alternative asset managers seeking healthcare-exposed infrastructure assets. The timing and scale of this transaction may generate significant competitive tension among qualified buyers given Lyric's market position in a resilient, regulated industry segment.
Lyric operates within the healthcare industry's payments infrastructure, providing software solutions that support payment processing and integrity in the healthcare sector. This positioning places the company at the intersection of two structural growth trends: digital transformation of healthcare operations and increasing focus on payment accuracy and compliance. The $5 billion valuation reflects the strategic value assigned to this business segment within TPG's portfolio.
The sale process underscores ongoing consolidation activity within healthcare technology and fintech sectors, where software platforms addressing mission-critical payment and regulatory functions command premium valuations. With JPMorgan coordinating the process, potential bidders likely span strategic buyers in healthcare services, payment processors, software-as-a-service providers, and alternative asset managers seeking healthcare-exposed infrastructure assets. The timing and scale of this transaction may generate significant competitive tension among qualified buyers given Lyric's market position in a resilient, regulated industry segment.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.